MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) Research

Based in Geneva, Switzerland, MindMaze Therapeutics Holding SA specializes in the creation of artificial intelligence-driven neurotherapeutics and pharmacological solutions. The company's primary focus is on addressing a range of neurological and neuropsychiatric conditions through a combination of advanced research, thorough clinical development, and cutting-edge technological applications.

Market snapshot

Symbol
RLFTY
Price
$0.42
Day change
0.00%
Market cap
$28.1M
P/E ratio
-2.83x
52-week range
0.2731-4.05
Sector
Industrials
Industry
Specialty Business Services

Peer companies

  • Arch Biopartners Inc. (ACHFF)
  • Calliditas Therapeutics Ab (CLTEF)
  • Helix BioPharma Corp. (HBPCF)
  • Amplia Therapeutics Limited (INNMF)
  • Oncotelic Therapeutics, Inc. (OTLC)
  • PsyBio Therapeutics Corp. (PSYBF)
  • Sernova Corp. (SEOVF)
  • Vext Science, Inc. (VEXTF)

Open MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.